Scholars Central

PerspectivePublished 30 Sep 2022

In hospitalized COVID-19 patients, face-mask sampling was used to measure the amount of exhaled SARS-CoV-2

Authors: Ashley Wruble

Clinical Investigation

Volume 12 · Issue 9 · Pages 181–182

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The respiratory pathway is what drives SARS-CoV-2 transmission from person to person, although little is known about the pattern and volume of viral production from exhaled breath. Face-Mask Sampling (FMS), which we have previously demonstrated is capable of detecting exhaled tubercle bacilli, has been modified for use in quantifying exhaled SARS-CoV-2 RNA in patients admitted to hospitals with Coronavirus Disease-2019 (COVID-19).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Investigation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Ashley Wruble”